You are here:
The Prescription Drug Price Transparency Act requires prescription drug manufacturers to report on new prescription drugs with a price exceeding $670 (the Medicare Part D specialty drug cost threshold). Once a drug report has been received, the department will post the name of the manufacturer and the prescription drug that is the subject of the filing.
View the list of new drug reports
Oregon’s Prescription Drug Price Transparency Program requires health insurance companies to report on prescription drugs in Oregon. Health insurance companies reported the 25 most prescribed drugs, the 25 most costly prescription drugs, and the 25 prescription drugs which caused the biggest increases in yearly health plan spending in 2018.
The program combined these lists to see which drugs were reported and ranked highest by the different insurers.
Read the program’s report here (PDF).
The combined lists and the individual insurer lists can be found at the following links.
Top 25 most frequently prescribed drugs.
Top 25 most frequently prescribed drugs as reported by each insurance company.
Top 25 most costly drugs
Top 25 most costly drugs as reported by each insurance company
Top 25 drugs causing the greatest increase in insurance spending
Top 25 drugs causing the greatest increase in insurance spending as reporter by each insurance company
Download formatted versions of these lists (XSLX) in a single Excel file. The combined lists in this file contain additional information about each drug, including therapeutic classes, FDA approval dates, and whether generic versions of the drugs were available in 2018.
Download PDF versions of the original lists submitted to the program (ZIP) by the insurers.
Download the R computer code used to combine the lists, along with the raw Excel files used (ZIP).
Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how
×